Related references
Note: Only part of the references are listed.Molecular Pathways: Multimodal Cancer-Killing Mechanisms Employed by Oncolytic Vesiculoviruses
Douglas J. Mahoney et al.
CLINICAL CANCER RESEARCH (2013)
Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic viruses
K-W Peng et al.
GENE THERAPY (2013)
Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: Role of type I interferon signaling
Megan Moerdyk-Schauwecker et al.
VIROLOGY (2013)
Potent systemic therapy of multiple myeloma utilizing oncolytic vesicular stomatitis virus coding for interferon-β
S. Naik et al.
CANCER GENE THERAPY (2012)
Oncolytic Virus Therapy for Glioblastoma Multiforme Concepts and Candidates
Guido Wollmann et al.
CANCER JOURNAL (2012)
Bugs and Drugs: Oncolytic Virotherapy in Combination with Chemotherapy
Sonia Tusell Wennier et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2012)
Radiovirotherapy: Principles and Prospects in Oncology
Y. Touchefeu et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
The tumor microenvironment is a dominant force in multidrug resistance
Ana Luisa Correia et al.
DRUG RESISTANCE UPDATES (2012)
Targeting the Interleukin-6/Jak/Stat Pathway in Human Malignancies
Pasquale Sansone et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer
Eric Hastie et al.
JOURNAL OF GENERAL VIROLOGY (2012)
Oncolytic virotherapy
Stephen J. Russell et al.
NATURE BIOTECHNOLOGY (2012)
NK cells impede glioblastoma virotherapy through NKp30 and NKp46 natural cytotoxicity receptors
Christopher A. Alvarez-Breckenridge et al.
NATURE MEDICINE (2012)
Clinical development directions in oncolytic viral therapy
R. M. Eager et al.
CANCER GENE THERAPY (2011)
Use of Macrophages to Target Therapeutic Adenovirus to Human Prostate Tumors
Munitta Muthana et al.
CANCER RESEARCH (2011)
Strategies to Enhance Viral Penetration of Solid Tumors
Elspeth Smith et al.
HUMAN GENE THERAPY (2011)
Dual Roles of Immune Cells and Their Factors in Cancer Development and Progression
Brian F. Zamarron et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2011)
Vesicular Stomatitis Virus Has Extensive Oncolytic Activity against Human Sarcomas: Rare Resistance Is Overcome by Blocking Interferon Pathways
Justin C. Paglino et al.
JOURNAL OF VIROLOGY (2011)
Targeting Tumor Vasculature With an Oncolytic Virus
Caroline J. Breitbach et al.
MOLECULAR THERAPY (2011)
Thunder and Lightning: Immunotherapy and Oncolytic Viruses Collide
Alan Melcher et al.
MOLECULAR THERAPY (2011)
CANCER Macrophages limit chemotherapy
Michele De Palma et al.
NATURE (2011)
Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy
David G. DeNardo et al.
CANCER DISCOVERY (2011)
Reciprocal activation of macrophages and breast carcinoma cells by nitric oxide and colony-stimulating factor-1
Cheng-Wei Lin et al.
CARCINOGENESIS (2010)
Combining oncolytic virotherapy and tumour vaccination
Byram W. Bridle et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2010)
Herpes simplex virus oncolytic vaccine therapy in melanoma
Shanthi Sivendran et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Evaluation of an Attenuated Vesicular Stomatitis Virus Vector Expressing Interferon-beta for Use in Malignant Pleural Mesothelioma: Heterogeneity in Interferon Responsiveness Defines Potential Efficacy
Vassiliki Saloura et al.
HUMAN GENE THERAPY (2010)
Engineering oncolytic viruses to exploit tumor specific defects in innate immune signaling pathways
Shruthi Naik et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation
Alberto Mantovani et al.
HUMAN IMMUNOLOGY (2009)
MicroRNAs and the Regulation of Vector Tropism
Elizabeth J. Kelly et al.
MOLECULAR THERAPY (2009)
Oncolytic viruses: a novel form of immunotherapy
Robin J. Prestwich et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2008)
STAT2 is a primary target for measles virus V protein-mediated alpha/beta interferon signaling inhibition
Aparna Rarnachandran et al.
JOURNAL OF VIROLOGY (2008)
Immunosuppression enhances oncolytic adenovirus replication and antitumor efficacy in the Syrian hamster model
Maria A. Thomas et al.
MOLECULAR THERAPY (2008)
The tumor microenvironment and its role in promoting tumor growth
T. L. Whiteside
ONCOGENE (2008)
Mining for JAK-STAT mutations in cancer
Stefan N. Constantinescu et al.
TRENDS IN BIOCHEMICAL SCIENCES (2008)
Interferon-inducible antiviral effectors
Anthony J. Sadler et al.
NATURE REVIEWS IMMUNOLOGY (2008)
Radioiodide imaging and radiovirotherapy of multiple myeloma using VSV(Δ51)-NIS, an attenuated vesicular stomatitis virus encoding the sodium iodide symporter gene
Apollina Goel et al.
BLOOD (2007)
Inhibition of vesicular stomatitis virus infection in epithelial cells by alpha interferon-induced soluble secreted proteins
Mausumi Basu et al.
JOURNAL OF GENERAL VIROLOGY (2006)
VEGF-C expressing tumor-associated macrophages in lymphnode positive breast cancer: impact on lymphangiogenesis and survival
Sebastian F. Schoppmann et al.
SURGERY (2006)
Oncolytic virotherapy: Approaches to tumor targeting and enhancing antitumor effects
SH Thorne et al.
SEMINARS IN ONCOLOGY (2005)
Tumor-associated macrophages: The double-edged sword in cancer progression
JJW Chen et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Vesicular stomatitis virus: re-inventing the bullet
BD Lichty et al.
TRENDS IN MOLECULAR MEDICINE (2004)
Sensitivity of prostate tumors to wild type and M protein mutant vesicular stomatitis viruses
M Ahmed et al.
VIROLOGY (2004)
Vesicular stomatitis virus as an oncolytic vector
GN Barber
VIRAL IMMUNOLOGY (2004)
DNA methylation and expression of major histocompatibility complex class I and class II transactivator genes in human developmental tumor cells and in T cell malignancies
PJ van den Elsen et al.
CLINICAL IMMUNOLOGY (2003)
Innate immune response negative strand against nonsegmented RNA viruses
S Bose et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2003)
Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis
SF Schoppmann et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Genetically engineered vesicular stomatitis virus in gene therapy: Application for treatment of malignant disease
M Fernandez et al.
JOURNAL OF VIROLOGY (2002)
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus
DF Stojdl et al.
NATURE MEDICINE (2000)
Prognostic value of tumor-associated macrophage count in human bladder cancer
T Hanada et al.
INTERNATIONAL JOURNAL OF UROLOGY (2000)
Share Paper
